OP Asset Management Ltd Invests $2.11 Million in Healthpeak Properties, Inc. $DOC

OP Asset Management Ltd purchased a new position in Healthpeak Properties, Inc. (NYSE:DOC) in the first quarter, HoldingsChannel reports. The fund purchased 128,353 shares of the real estate investment trust’s stock, valued at approximately $2,109,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in Healthpeak Properties during the 4th quarter worth $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its position in shares of Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after purchasing an additional 4,776,056 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Healthpeak Properties by 42.7% during the fourth quarter. Bank of New York Mellon Corp now owns 9,641,231 shares of the real estate investment trust’s stock worth $155,031,000 after purchasing an additional 2,887,084 shares during the last quarter. Finally, Millennium Management LLC grew its stake in Healthpeak Properties by 235.3% in the fourth quarter. Millennium Management LLC now owns 3,512,223 shares of the real estate investment trust’s stock worth $56,477,000 after purchasing an additional 2,464,612 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Price Performance

DOC opened at $21.51 on Monday. The firm has a market cap of $14.83 billion, a price-to-earnings ratio of 67.22, a price-to-earnings-growth ratio of 3.36 and a beta of 1.05. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $21.56. The company’s 50-day moving average price is $19.06 and its 200 day moving average price is $17.67. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which was paid on Friday, June 26th. Investors of record on Monday, June 15th were issued a $0.1017 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 5.7%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Analysts Set New Price Targets

Several brokerages recently weighed in on DOC. Wells Fargo & Company boosted their price objective on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Robert W. Baird increased their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Royal Bank Of Canada lifted their target price on Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday, May 14th. Citigroup boosted their price target on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Evercore lowered Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a research report on Monday, May 11th. Three research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to MarketBeat.com, Healthpeak Properties has a consensus rating of “Hold” and an average target price of $19.93.

Insider Transactions at Healthpeak Properties

In related news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares in the company, valued at $148,520.20. The trade was a 59.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.23% of the stock is owned by corporate insiders.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.